Studie

German Treatment Optimization Study for Children with De Novo and Relapsed Langerhans cell Histiocytosis (LCH) as Part of the International Study LCH-IV

Erkrankungsgruppe:

ZNS und Gehirntumore

Organsystem:

Immunsystem

Stadium:

Ersterkrankung, Rückfall

Standort:

Dortmund, Essen

EudraCT:

2016-003568-38

Prüfplan-Code:

LCH-IV-G-2016

Phase:

II/III

Prüfsubstanz:

Prednison, Vinblastine, Mercaptopurine, Indomethacin, Methotrexate

Sponsor:

Johann Wolfgang Goethe-University Frankfurt am Main